At DCAT With Piramal Pharma Solutions

Published on: 


Peter DeYoung, CEO, Piramal Pharma Solutions, talks about recent company achievements and key offerings, as well as current industry trends.

At a recent Drug, Chemical & Associated Technologies (DCAT) conference, Pharmaceutical Technology spoke with Peter DeYoung, CEO, Piramal Pharma Solutions, to learn more about the company's offerings. Watch to learn more about:

  • Piramal's key service offerings and integrated solutions in the areas of oncology and ADCs.
  • The current operating environment for CDMOs and industry trends.
  • Piramal's strategy to expand its territorial footprint in the US beyond its existing facilities.